Cargando…
Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252353/ http://dx.doi.org/10.1016/S0168-8278(22)00819-4 |
| _version_ | 1784740244597243904 |
|---|---|
| author | Iavarone, Massimo Tosetti, Giulia Facchetti, Floriana Topa, Matilde Lombardi, Andrea D’Ambrosio, Roberta Degasperi, Elisabetta Loglio, Alessandro Oggioni, Chiara Bandera, Alessandra Gori, Andrea Ceriotti, Ferruccio Scudeller, Luigia Bertoletti, Antonio Lampertico, Pietro |
| author_facet | Iavarone, Massimo Tosetti, Giulia Facchetti, Floriana Topa, Matilde Lombardi, Andrea D’Ambrosio, Roberta Degasperi, Elisabetta Loglio, Alessandro Oggioni, Chiara Bandera, Alessandra Gori, Andrea Ceriotti, Ferruccio Scudeller, Luigia Bertoletti, Antonio Lampertico, Pietro |
| author_sort | Iavarone, Massimo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9252353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Association for the Study of the Liver. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92523532022-07-05 Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study Iavarone, Massimo Tosetti, Giulia Facchetti, Floriana Topa, Matilde Lombardi, Andrea D’Ambrosio, Roberta Degasperi, Elisabetta Loglio, Alessandro Oggioni, Chiara Bandera, Alessandra Gori, Andrea Ceriotti, Ferruccio Scudeller, Luigia Bertoletti, Antonio Lampertico, Pietro J Hepatol POSTER PRESENTATIONS: Thursday 23 June: Public Health European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252353/ http://dx.doi.org/10.1016/S0168-8278(22)00819-4 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | POSTER PRESENTATIONS: Thursday 23 June: Public Health Iavarone, Massimo Tosetti, Giulia Facchetti, Floriana Topa, Matilde Lombardi, Andrea D’Ambrosio, Roberta Degasperi, Elisabetta Loglio, Alessandro Oggioni, Chiara Bandera, Alessandra Gori, Andrea Ceriotti, Ferruccio Scudeller, Luigia Bertoletti, Antonio Lampertico, Pietro Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title | Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_full | Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_fullStr | Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_full_unstemmed | Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_short | Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| title_sort | humoral, cellular, clinical responses and safety to sars-cov-2 messanger rna vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study |
| topic | POSTER PRESENTATIONS: Thursday 23 June: Public Health |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252353/ http://dx.doi.org/10.1016/S0168-8278(22)00819-4 |
| work_keys_str_mv | AT iavaronemassimo humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT tosettigiulia humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT facchettifloriana humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT topamatilde humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT lombardiandrea humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT dambrosioroberta humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT degasperielisabetta humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT loglioalessandro humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT oggionichiara humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT banderaalessandra humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT goriandrea humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT ceriottiferruccio humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT scudellerluigia humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT bertolettiantonio humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy AT lamperticopietro humoralcellularclinicalresponsesandsafetytosarscov2messangerrnavaccinesinpatientswithcompensatedanddecompensatedcirrhosisalongtermsinglecenterprospectivestudy |